<DOC>
	<DOC>NCT00273052</DOC>
	<brief_summary>This study was designed to determine whether treatment with COREG MR is more effective at maintaining a better lipid profile than treatment with TOPROL-XL for hypertension.</brief_summary>
	<brief_title>COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Documented history of hypertension Triglycerides of 120400 mg/mL LDLc levels not requiring lipid lowering medication. Has known contraindication to alpha or betablocker therapy. Has taken any nonocular betablockers within three months before screening. Has Type I or II diabetes. Taking lipid lowering medications.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>hypertension</keyword>
</DOC>